HER-2 Negative Breast Cancer Market Primed to Witness High Growth due to Advancements in Targeted Therapy Drugs
HER-2 negative breast cancer, also known as HER2- breast cancer, accounts for around 70% of all breast cancer cases. It is characterized by the lack …